Myasthenia gravis: a clinical-immunological update

Myasthenia gravis (MG) is the archetypic disorder of both the neuromuscular junction and autoantibody-mediated disease. In most patients, IgG1-dominant antibodies to acetylcholine receptors cause fatigable weakness of skeletal muscles. In the rest, a variable proportion possesses antibodies to muscl...

Descripción completa

Detalles Bibliográficos
Autores principales: Binks, Sophie, Vincent, Angela, Palace, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Neurological Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826656/
https://www.ncbi.nlm.nih.gov/pubmed/26705120
http://dx.doi.org/10.1007/s00415-015-7963-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826656/
https://www.ncbi.nlm.nih.gov/pubmed/26705120
http://dx.doi.org/10.1007/s00415-015-7963-5

Ejemplares similares